If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Product Launch » Market Entry: Metabolic and Cardiovascular Diseases
Download FREE Excerpt
17 Info Graphics
21 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
The pharmaceutical industry is constantly developing and launching new metabolic products. While many factors affect a new metabolic product launch, physicians play an important role in a product's market entry. Some of the key interactions between pharma and physicians that affect a launch include initial trials, thought leader engagement, early education and use of new technologies.
Best Practices, LLC conducted this study to surface strategies and tactics to address each of these important physician-related areas that are part of a successful metabolic product launch. Marketing and launch leaders can use this research to compare their approach to these physician-related launch interactions with the approaches used by leading organizations. This study includes two segments: one representing the entire benchmark class and one representing the metabolic therapeutic area.
The research employed a data gathering approach that gleaned quantitative data from Nine leaders in metabolics, although their participation varied across the question set. The total benchmark class included 44 executives and managers from 38 leading companies in pharmaceutical, biotechnology and medical device industries. In addition, nine executives participated in in-depth interviews.